Associated equity: Creo Medical
UK-based Creo Medical focuses on the development and commercialisation of minimally invasive electrosurgical devices. Its six products in the flagship CROMA platform have all been CE marked, with five cleared by the FDA. Acquired in 2020, Albyn Medical provides Creo with profitable products and a direct salesforce in Europe.
Creo Medical — 1 video in collection
Get access to the very latest content matched to your personal investment style.